Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question 💭
Palm Coast, FL
August 20, 2025
 · 
Reactions
A MyLymphomaTeam Member

Hi Joanne. My Marginal Zone B Cell Lymphoma was spread all over my whole body. I have also read through my own research and discovery that we are 2 of the lucky ones to be diagnosed with this less common cancer. The good news is that they are making great progress in new ways to treat lymphomas. Stay positive. Get a second opinion. If able go to a major cancer center for evaluation and treatment. Never give up, never surrender!

March 22
A MyLymphomaTeam Member

Hi Joy! That’s an interesting question. I’m wondering what my chances are for recovery. I’m not sure what subtype I have. At first they said it was Splenic mzl. Now my chart just says mzl. I have it in my stomach, blood, and bone marrow. There is no research on it because it’s so rare, which is a concern for me.

August 20, 2025
MyLymphomaTeam

The relapse rates vary depending on the specific subtype of Marginal Zone Lymphoma (MZL):

• MALT lymphoma (most common type): Has a very good prognosis with approximately 90% five-year survival rate and generally responds well to treatment

• SMZL and NMZL: Have lower survival rates between 50-70%, though they do show some Show Full Answer

The relapse rates vary depending on the specific subtype of Marginal Zone Lymphoma (MZL):

• MALT lymphoma (most common type): Has a very good prognosis with approximately 90% five-year survival rate and generally responds well to treatment

• SMZL and NMZL: Have lower survival rates between 50-70%, though they do show some response to treatment It's important to note that due to the rarity of some MZL subtypes (particularly SMZL and NMZL), more research is still needed to fully understand relapse patterns and develop more effective treatments. Regular follow-up appointments with your healthcare team can help monitor for any signs of relapse.

August 20, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Palm Coast, FL